Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey.

Published

Journal Article

OBJECTIVES: This study sought to determine clinician and scientist involvement in heart failure (HF) clinical research and to describe the challenges of conducting clinical trials in the United States. BACKGROUND: Improvements in the current capability, potential, and deficiencies of the HF clinical research infrastructure in the United States are needed in order to enhance efficiency and impact. METHODS: The Heart Failure Society of America (HFSA) distributed an electronic survey regarding HF clinical trial activity for the purpose of understanding the barriers that exist to conducting high-quality HF clinical research. RESULTS: Overall, 1,794 HFSA members were queried, and 434 members (24%) completed surveys, whereas a total of 7,589 individuals with interest in HF were queried, and 615 completed surveys. Of the respondents, 410 (67%) were actively engaged in HF research and 120 (20%) were interested in research. Most respondents, 270, were physicians (44%); 311 of the total (76% of the total and 80% of physicians) practiced in academic institutions; 333 respondents (81%) had served as principal investigators and 73 (18%) as site coordinators. Respondents active in clinical research usually participated in 1 to 5 trials and enrolled 1 to 20 patients annually. Institutional review board (IRB) approval typically required 3 months, and contract completion required 3 to 6 months per site. The greatest barriers to research were insufficient site budgets, delay in contracting, inability to find participants meeting trial entry criteria, and unavailability of qualified study coordinators. CONCLUSIONS: Many U.S. clinical research sites are constrained by budgetary, staffing, and contractual issues. The HFSA Research Network seeks to unify interested sites and deconstruct barriers to permit high-value HF research.

Full Text

Duke Authors

Cited Authors

  • Psotka, MA; Ammon, SE; Fiuzat, M; Bozkurt, B; Chung, ES; Cole, RT; Greene, SJ; Kraus, D; Ky, B; McIlvennan, CK; Shah, P; Teerlink, JR; Walsh, MN; Jessup, M; O'Connor, CM

Published Date

  • May 2019

Published In

Volume / Issue

  • 7 / 5

Start / End Page

  • 431 - 438

PubMed ID

  • 30981742

Pubmed Central ID

  • 30981742

Electronic International Standard Serial Number (EISSN)

  • 2213-1787

Digital Object Identifier (DOI)

  • 10.1016/j.jchf.2019.02.008

Language

  • eng

Conference Location

  • United States